Idorsia seeks fourth CEO in two years Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M T W Th Fri 20 March, 2026

AI-driven drug discovery is already reshaping pipelines. But algorithms alone won’t get a drug to the clinic. Join us for a free virtual program — then continue the conversation at an in-person only fireside chat and happy hour in Boston. Reserve your spot.

presented by 5 ways to se­cure biotech fund­ing in 2026

news Novartis to pay $2B upfront to take next-gen version of its breast cancer drug Piqray Genentech culls muscle-preserving drug in genetic diseases, raising questions about obesity trial Peer Review Idorsia looks for another CEO — again; Former Jazz exec makes a comeback Turmoil at ACIP continues after claim committee ‘disbanded’ is quickly refuted

Mar 24 11:30 am ET From structure to selectivity: Federated AI for collaborative binding affinity prediction sponsored by Rhino Federated Computing

Head of Regulatory Strategy TCG stealth clinic-ready newco Boston, MA, USA Senior Director, Licensing Officer Bayer Cambridge, MA, USA Recruit talent with Endpoints Careers Contact Meg Estacio: mestacio@endpointsnews.com

US biopharma still leads the world in high-risk drug development, but the road from innovation to access has never been harder to predict. Hear from top executives and investors on how they’re navigating what’s next. Join us. UTMs:

endpoints pharma FDA approves GSK liver drug at center of Alfasigma deal Novo wins FDA approval for high-dose Wegovy under commissioner's voucher CSL says hemophilia B gene therapy is temporarily out of stock, warns of treatment delays Exclusive: Verily raises $300M, sheds Alphabet’s majority control

in case you missed it 1. Updated: Lilly’s triple-G comparable with Mounjaro, first Phase 3 diabetes data suggest 2. AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plans 3. Collegium is acquiring Corium's approved ADHD drug for $650M 4. Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 win 5. Exclusive: Congruence raises $40M, enters clinic with lead obesity drug 6. Ozempic Copies to Cost $14 in India as Generic GLP-1 Era Starts 7. Stress can cause eczema to flare-up – now we know why